Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

5AM Venture Management, LLC 13F Holdings -- Portfolio & Top Positions (2026-06-30)

5AM Venture Management, LLC (CIK 1799883) reported $287.9M across 16 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: MPLT ($34.0M, 11.83%), TYRA ($32.9M, 11.42%), TRDA ($29.9M, 10.37%), PHVS ($27.6M, 9.58%), CAMP ($25.6M, 8.91%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1MPLTMAPLIGHT THERAPEUTICS INC$34.0M11.83%950,011Hold
2TYRATYRA BIOSCIENCES INC$32.9M11.42%1.0MHold
3TRDAENTRADA THERAPEUTICS INC$29.9M10.37%4.1MHold
4PHVSPHARVARIS N V$27.6M9.58%797,600Hold
5CAMPCAMP4 THERAPEUTICS CORP$25.6M8.91%5.9MHold
6ARTVARTIVA BIOTHERAPEUTICS INC$22.8M7.93%2.4MHold
7TECXTECTONIC THERAPEUTIC INC$20.9M7.24%606,660Hold
8ZNTLZENTALIS PHARMACEUTICALS INC$19.1M6.65%3.9MHold
9CLDXCELLDEX THERAPEUTICS INC NEW$18.5M6.43%497,270Hold
10EYPTEYEPOINT INC$15.0M5.22%1.1MHold
11BHVNBIOHAVEN LTD$11.0M3.82%738,972Hold
12SRZNSURROZEN INC$7.0M2.44%271,250Trimmed
13SKYESKYE BIOSCIENCE INC$6.7M2.33%9.7MHold
14ALXOALX ONCOLOGY HLDGS INC$6.3M2.20%3.1MHold
15TARAPROTARA THERAPEUTICS INC$5.2M1.82%1.4MHold
16SLNSILENCE THERAPEUTICS PLC$5.2M1.82%476,200Hold
17CNTACENTESSA PHARMACEUTICALS PLC$00.00%0Exited
18ERASERASCA INC$00.00%0Exited
19RLYBRALLYBIO CORP$00.00%0Exited
20GHRSGH RESEARCH PLC$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-06-30